MARIA CATALANO: Open Payments
NPI 1073186193 · CLEARWATER, FL. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$3,283 in 201 payments from 17 companies in 2025. Trend: 2023 $44 · 2024 $1,659 · 2025 $3,283
Food & beverage: $3,171Education: $111
| Company | Payments | Amount |
|---|---|---|
| ABBVIE INC. | 27 | $530 |
| Teva Pharmaceuticals USA, Inc. | 35 | $432 |
| Neurocrine BioSciences, Inc. | 42 | $412 |
| Janssen Pharmaceuticals, Inc | 14 | $298 |
| ITI, Inc. (d/b/a Intra-Cellular Therapies, Inc.) | 17 | $286 |
| Axsome Therapeutics, Inc. | 10 | $273 |
| Alkermes, Inc. | 11 | $197 |
| E.R. Squibb & Sons, L.L.C. | 10 | $195 |
| Vanda Pharmaceuticals Inc. | 8 | $181 |
| Otsuka America Pharmaceutical, Inc. | 10 | $175 |
Products named: VRAYLAR, INGREZZA, CAPLYTA, Auvelity, AUSTEDO XR, INVEGA, COBENFY, ARISTADA.
Industry payments across FL — which companies pay providers there.
